Teleflex Announces Urology Times Article Highlighting the UroLift System as Providing a Superior Patient Experience for Treating Enlarged Prostate
September 16, 2019
Minimally Invasive Treatment Options for BPH Remain Critical Due to Shortcomings of Surgery and Medication
Read MoreTeleflex Announces Publication of a Large Real-World Study Confirming Results from Controlled Clinical Studies of the UroLift® System
July 9, 2019
Results from Multi-Center Study Support the Application of Minimally Invasive Treatment for Broader BPH Population
Read MoreTeleflex Announces Expanded Nationwide Coverage for the UroLift System for Patients with Enlarged Prostate
June 26, 2019
Coverage Decision by Anthem Increases Access to Minimally Invasive Treatment, Offering Patients Rapid, Durable Symptom Relief
Read MoreTeleflex Announces Positive Results from Five Studies Underscoring the Effectiveness and Versatility of the UroLift® System Treatment for BPH
May 6, 2019
Real-World Data Presented at American Urological Association Meeting Highlight Consistency with Controlled Studies and Effectiveness in Diverse...
Read MoreTeleflex Announces Multiple Data Presentations from Studies of the UroLift® System Treatment for Enlarged Prostate at the American Urological Association 2019 Meeting
May 1, 2019
Data featuring real-world findings in a large, multi-center study, and effectiveness and sexual function preservation in diverse patient populations...
Read MoreTeleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate
March 20, 2019
Findings Presented at European Association of Urology Show Consistent Positive Results for Minimally Invasive UroLift System Treatment
Read MoreNeoTract Announces 100,000 Patients Treated for Enlarged Prostate with UroLift® System
February 21, 2019
Minimally Invasive UroLift System Treatment Provides Rapid Symptom Relief and Improved Quality of Life, While Preserving Sexual Function*1,2
Read MoreNeoTract Announces Expanded Coverage for UroLift System Treatment for Patients with Enlarged Prostate
February 14, 2019
Favorable Coverage Decisions Broaden Access to This Minimally Invasive Treatment That Provides Rapid Relief and Recovery from Symptoms
Read MoreData Suggest That Men Should Resolve to Address Their BPH Symptoms in 2019
January 16, 2019
NeoTract Study Finds That Men Over 40 Are Not Aware that Delaying Treatment of Benign Prostatic Hyperplasia (BPH) Can Cause Permanent Bladder Damage...
Read More12-Month Results from Study of NeoTract’s UroLift® System for BPH in Men with an Obstructive Median Lobe Published in Prostate Cancer and Prostatic Diseases
December 14, 2018
PLEASANTON, Calif. – December 14, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in...
Read More
